跳至主要内容
临床试验/NCT06798688
NCT06798688尚未招募不适用

Software Algorithm Using Machine Learning and Threshold Based Methods for Predicting Exacerbations and Deterioration

Respiree Pte Ltd0 个研究点目标入组 20 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
20
主要终点
Identifying readmissions using respiratory biomarkers

研究概览

简要总结

In this study, the sponsor would like to collaborate with Institution and Investigator to aggregate participants data and to pilot its software algorithm using machine learning and threshold based methods for predicting exacerbations and deterioration within a 60 days period post-discharge.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject age 18 or older
  • •Receives all primary and specialty care at Institution
  • •Participants will be enrolled at discharge (and not designate hospital or ED)
  • •A history of one of the following diagnoses:
  • •a. c. Chronic obstructive pulmonary disease
  • •At least two documented exacerbations of the above disease in the past 12 months as defined by the following corresponding criteria:
  • •a. Chronic obstructive pulmonary disease exacerbation: all three of (1) increase in frequency and severity or severity of cough, (2) increase in volume and/or change of character of sputum production, and (3) increase in dyspnea, and requiring treatment with short-acting bronchodilators, antibiotics, and oral or intravenous glucocorticoids.
  • •Participants able to provide informed consent.
  • •Participants will be enrolled at discharge (and not designate hospital or ED)

排除标准

  • •Participants with neuromuscular diseases and seizures
  • •Participants enrolled in hospice care or life expectancy less than three months.
  • •Participants living more than 60 miles away from Institution and Investigator
  • •Participants with expected out of state travel within a 30-day period or travel to a location with no internet access.

结局指标

主要结局

Identifying readmissions using respiratory biomarkers

时间窗: 60-days

To validate respiratory-based biomarkers in models to predict exacerbations - benchmarking to be done versus physician assess exacerbations, emergency department visits, hospitalizations and any other visit.

次要结局

  • Validate compliance and usability(60-days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

In This Study, the Sponsor Would Like to Collaborate... | 临床试验